Search Results - A. V. Syrov

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    PHARMACO-ECONOMIC COMPARISON OF ENOXAPARIN AND UNFRACTIONATED HEPARIN IN ACUTE CORONARY SYNDROME WITHOUT ST SEGMENT ELEVATION by A. V. Syrov, S. K. Zyryanov, Yu. B. Belousov

    Published 2010-04-01

    Acute coronary syndrome (ACS) is a form of coronary heart disease (CHD), combining acute myocardial infarction with ST segment elevation (STE ACS), acute myocardial infarction without ST segment elevation, and unstable angina (non-STE ACS). These clinical forms are considered as one syndrome, due to...

    Full description

    Get full text
    Article
  2. 2

    Management of patients with comorbidity during novel coronavirus (COVID-19) pandemic. National Consensus Statement 2020 by V. B. Grinevich, I. V. Gubonina, V. L. Doshchitsin, Yu. V. Kotovskaya, Yu. A. Kravchuk, V. I. Ped, E. I. Sas, A. V. Syrov, A. V. Tarasov, A. I. Tarzimanova, O. N. Tkacheva, D. I. Trukhan

    Published 2020-09-01

    The pandemic of the novel coronavirus infection (COVID-19), caused by SARS‑CoV‑2, has become a challenge to healthcare systems in all countries of the world. Patients with comorbidity are the most vulnerable group with the high risk of adverse outcomes. The problem of managing these patients in cont...

    Full description

    Get full text
    Article
  3. 3